全文获取类型
收费全文 | 12343篇 |
免费 | 102篇 |
国内免费 | 3篇 |
专业分类
电工技术 | 52篇 |
综合类 | 5篇 |
化学工业 | 565篇 |
金属工艺 | 75篇 |
机械仪表 | 66篇 |
建筑科学 | 126篇 |
矿业工程 | 4篇 |
能源动力 | 92篇 |
轻工业 | 291篇 |
水利工程 | 22篇 |
石油天然气 | 6篇 |
武器工业 | 1篇 |
无线电 | 366篇 |
一般工业技术 | 617篇 |
冶金工业 | 9502篇 |
原子能技术 | 48篇 |
自动化技术 | 610篇 |
出版年
2021年 | 26篇 |
2020年 | 24篇 |
2019年 | 34篇 |
2018年 | 44篇 |
2017年 | 48篇 |
2016年 | 35篇 |
2015年 | 40篇 |
2014年 | 79篇 |
2013年 | 185篇 |
2012年 | 80篇 |
2011年 | 122篇 |
2010年 | 109篇 |
2009年 | 109篇 |
2008年 | 114篇 |
2007年 | 132篇 |
2006年 | 98篇 |
2005年 | 89篇 |
2004年 | 93篇 |
2003年 | 106篇 |
2002年 | 86篇 |
2001年 | 94篇 |
2000年 | 91篇 |
1999年 | 372篇 |
1998年 | 2986篇 |
1997年 | 1668篇 |
1996年 | 1101篇 |
1995年 | 652篇 |
1994年 | 517篇 |
1993年 | 620篇 |
1992年 | 116篇 |
1991年 | 158篇 |
1990年 | 150篇 |
1989年 | 145篇 |
1988年 | 148篇 |
1987年 | 144篇 |
1986年 | 130篇 |
1985年 | 110篇 |
1984年 | 62篇 |
1983年 | 62篇 |
1982年 | 78篇 |
1981年 | 86篇 |
1980年 | 128篇 |
1979年 | 58篇 |
1978年 | 54篇 |
1977年 | 237篇 |
1976年 | 520篇 |
1975年 | 50篇 |
1974年 | 33篇 |
1972年 | 24篇 |
1966年 | 22篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
951.
K Micha?lsson JA Baron BY Farahmand O Johnell C Magnusson PG Persson I Persson S Ljunghall 《Canadian Metallurgical Quarterly》1998,316(7148):1858-1863
OBJECTIVE: To determine the relative risk of hip fracture associated with postmenopausal hormone replacement therapy including the effect of duration and recency of treatment, the addition of progestins, route of administration, and dose. DESIGN: Population based case-control study. Setting: Six counties in Sweden. SUBJECTS: 1327 women aged 50-81 years with hip fracture and 3262 randomly selected controls. MAIN OUTCOME MEASURE: Use of hormone replacement therapy. RESULTS: Compared with women who had never used hormone replacement therapy, current users had an odds ratio of 0.35 (95 % confidence interval 0.24 to 0.53) for hip fracture and former users had an odds ratio of 0.76 (0.57 to 1.01). For every year of therapy, the overall risk decreased by 6% (3% to 9%): 4% (1% to 8%) for regimens without progestin and 11% (6% to 16%) for those with progestin. Last use between one and five years previously, with a duration of use more than five years, was associated with an odds ratio of 0.27 (0.08 to 0.94). After five years without hormone replacement therapy the protective effect was substantially diminished (-7% to 48%). With current use, an initiation of therapy nine or more years after the menopause gave equally strong reduction in risk for hip fracture as an earlier start. Oestrogen treatment with skin patches gave similar risk estimates as oral regimens. CONCLUSIONS: Recent use of hormone replacement therapy is required for optimum fracture protection, but therapy can be started several years after the menopause. The protective effect increases with duration of use, and an oestrogen-sparing effect is achieved when progestins are included in the regimen. 相似文献
952.
JA van Eijck 《Canadian Metallurgical Quarterly》1998,142(7):372, author reply 372-372, author reply 373
953.
OBJECTIVE: To demonstrate the reversibility of retrograde ventriculo-atrial block by isoproterenol in patients with atrioventricular nodal reentrant tachycardia (AVNRT). DESIGN: Three case reports and their electrophysiological features. PATIENTS: Three patients with documented or suspected paroxysmal supraventricular tachycardia. INTERVENTIONS: At routine electrophysiology study, no supraventricular tachycardia was inducible in the baseline state. Infusion of isoproterenol (1 to 5 micrograms/min) was given and stimulation procedures were repeated. RESULTS: At baseline, all three patients had discontinuous antegrade atrioventricular (AV) nodal conduction, but very poor (two patients) or absent (one patient) ventriculo atrial conduction prevented induction of AVNRT. During infusion of isoproterenol, retrograde conduction was enhanced so that 1:1 retrograde occurred to cycle lengths of 300, 340 and 260 ms. AVNRT was then inducible in all patients, reproducing their clinical symptoms. CONCLUSION: Absent or poor ventriculo-atrial conduction in patients with suspected AV node reentry does not preclude the development of tachycardia with sympathomimetic enhancement. Isoproterenol should be given to attempt reversal of retrograde block in these patients. 相似文献
954.
955.
Marijuana is a widely abused recreational drug well known for its psychoactive properties. Cannabinoids, the active ingredients of marijuana, elicit their neurobehavioral effects by interacting with the CB1 cannabinoid receptor subtype, expressed primarily in the brain but also present in some peripheral tissues. A second receptor subtype, the CB2 receptor, is expressed on cells of the immune system and is thought to be responsible for the immunosuppressant effects of cannabinoids. Recently, endogenous lipidlike substances have been identified, including arachidonyl ethanolamide (anandamide) and 2-arachidonyl glyceride, that bind to cannabinoid receptors and mimic many of the neurobehavioral effects of plant-derived cannabinoids. Both plant-derived cannabinoids and the endogenous ligands have been shown to elicit hypotension and bradycardia via activation of peripherally located CB1 receptors. Possible underlying mechanisms include presynaptic CB1 receptor mediated inhibition of norepinephrine release from peripheral sympathetic nerve terminals, and/or direct vasodilation via activation of vascular cannabinoid receptors. The latter may also be the target of endocannabinoids of vascular endothelial origin. Recent studies indicate that a peripheral endogenous cannabinoid system in circulating macrophages and platelets is activated in hemorrhagic and septic shock and may contribute to the hypotension associated with these conditions via activation of vascular cannabinoid receptors. The potential role of this mechanism in human shock conditions is under investigation. 相似文献
956.
MM Hudson CA Poquette J Lee CA Greenwald A Shah X Luo EI Thompson JA Wilimas LE Kun WM Crist 《Canadian Metallurgical Quarterly》1998,16(11):3592-3600
PURPOSE: To determine the impact of treatment toxicity on long-term survival in pediatric Hodgkin's disease. PATIENTS AND METHODS: We studied late events in 387 patients treated for pediatric Hodgkin's disease on four consecutive clinical trials at St Jude Children's Research Hospital from 1968 to 1990. Relative risks, actuarial risks, and absolute excess risks for cause-specific deaths were calculated. RESULTS: As of April 1997, 316 (82%) of patients were alive, with a median follow-up of 15.1 (range, 2.9 to 28.6) years. In this cohort, which represented 5,623 person-years of follow-up, 71 fatal events resulted from Hodgkin's disease (n=36), second malignancies (n=14), infections (n=7), accidents (n=7), cardiac disease (n=6), and asphyxiation (n=1). The 5-year estimated event-free survival (EFS) for the entire cohort was 79.6%+/-2.1 %, which declined to 63.1%+/-4.4% by 20 years. Cumulative incidences of cause-specific deaths at 25 years were 9.8%+/-1.6% for Hodgkin's disease, 8.1%+/-2.6% for second malignancy, 4.0%+/-1.8% for cardiac disease, 3.9%+/-1.5% for infection, and 2.1%+/-0.8% for accidents. Standardized incidence ratios showed excess risk for all second malignancies (12; 95% confidence interval [CI], 8 to 17), acute myeloid leukemia (81; 95% CI, 16 to 237), solid tumors (11; 95% CI, 7 to 16), and breast cancer (33; 95% CI, 12 to 72). Standardized mortality ratios also showed excess mortality from cardiac disease (22; 95% CI, 8 to 48) and infection (18; 95% CI, 7 to 38). CONCLUSION: Compared with age- and sex-matched control populations, survivors of pediatric Hodgkin's disease who were treated before 1990 face an increased risk of early mortality related to second cancers, cardiac disease, and infection. 相似文献
957.
Using multiple linear regression analyses, we examined the effects of subject status for 6 demographic variables and the presence of psychopathology on variance in MMPI-2 scale scores. The analyses were designed to measure the incremental contribution of the demographic variables to scale variance beyond that explained by presence of psychopathology. Demographic variables were found to contribute little incremental variance for the validity and clinical scales, but did explain more than 10% of the score variance for 1 clinical scale, 2 content scales, and 5 supplemental scales. For these 8 scales, gender was most often the potent demographic variable and an expected influence. The results are discussed in light of the use of gender-based norms and in terms of other potential factors that might explain MMPI-2 scale score variance. 相似文献
958.
959.
TF Davenport JR Albright JH Goldman SL Hagopian JE Lannutti KW Lai J LeBritton YC Lin AE Pifer HC Fenker DR Green GE Canough CC Chang TC Davis RW Joyner JA Poirier CH Georgiopoulos A Napier JM Marraffino JW Waters MS Webster EG Williams J Woosley JR Ficenec S Torres WP Trower 《Canadian Metallurgical Quarterly》1986,33(9):2519-2527
960.
JD Fritz I Danko SL Roberds KP Campbell JS Latendresse JA Wolff 《Canadian Metallurgical Quarterly》1995,37(6):693-700
The expression of full-length dystrophin and various dystrophin deletion mutants was monitored in mdx mouse muscle after intramuscular injection of dystrophin-encoding plasmid DNAs. Recombinant dystrophin proteins, including those lacking either the amino terminus, carboxyl terminus, or most of the central rod domain, showed localization to the plasma membrane. This suggests that there are multiple attachment sites for dystrophin to the plasma membrane. Only those constructs containing the carboxyl terminus were able to stabilize dystrophin-associated proteins (DAP) at the membrane, consistent with other studies that suggest that this domain is critical to DAP binding. Colocalization with DAP was not necessary for membrane localization of the various dystrophin molecules. However, stabilization and co-localization of the DAP did seem to be a prerequisite for expression and/or stabilization of mutant dystrophins beyond 1 wk and these same criteria seemed important for mitigating the histopathological consequences of dystrophin deficiency. 相似文献